Pepsin-induced modification of silver nanoparticles in simulated gastric fluid
Source abstract
Abstract
Abstract The behavior of AgNPs in simulated gastric fluids (SGFs) with and without pepsin was studied through time-dependent UV–Vis absorption spectroscopy and transmission electron microscopy. The dissolution at the initial stage and the subsequent particle growth and aggregation were observed in the absence of pepsin in SGF. On the other hand, individual AgNPs were protected via the formation of protein corona when pepsin was introduced into SGF. In addition, the agglomeration of AgNPs continued in SGF with pepsin, and gap narrowing between AgNPs was observed during the agglomeration. Flocculation eventually occurred as a result of continuous agglomeration. In addition, the degree of the agglomeration of AgNPs was found to be determined by the relative quantity of nanoparticles and pepsin. The experimental results indicate that the status of individual NPs and their congregative characteristics should be considered in the evaluation of the safety and toxicity of nanometer-scale materials.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Recycling and Waste Management Techniques · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Localized surface plasmon resonance optical characteristics for hydrogen peroxide using polyvinylpyrrolidone coated silver nanoparticles10.1016/j.matlet.2010.06.054 ↗
2. Catalytic properties of silver nanoparticles supported on silica spheres10.1021/jp046032g ↗
3. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli10.1007/s00253-009-2159-5 ↗
4. Green synthesis of controlled size gold and silver nanoparticles using antioxidant as capping and reducing agent10.1016/j.colcom.2020.100322 ↗
5. Biofabricated smart-nanosilver : promising armamentarium for cancer and pathogenic diseases10.1016/j.colcom.2021.100459 ↗
6. Characterization, antimicrobial, antioxidant, and anticoagulant activities of silver nanoparticles synthesized from Petiveria alliacea L. leaf extract10.1080/10826068.2018.1479864 ↗
7. Materials today : proceedings green synthesis of silver nanoparticles from Allium cepa and its in vitro antidiabetic activity10.1016/j.matpr.2019.07.672 ↗
8. Negligible particle-specific antibacterial activity of silver nanoparticles10.1021/nl301934w ↗
9. Silver nanoparticles modified nanocapsules for ultrasonically activated drug delivery10.1016/j.msec.2012.07.006 ↗
10. Silver nanowire-based transparent, flexible, and conductive thin film10.1186/1556-276X-6-75 ↗
11. Highly flexible silver nanowire electrodes for shape-memory polymer light-emitting diodes10.1002/adma.201003398 ↗
12. Scalable coating and properties of transparent, flexible, silver nanowire electrodes10.1021/nn1005232 ↗
13. Highly conductive and stretchable silver nanowire conductors10.1002/adma.201201886 ↗
14. Oral ingestion of silver nanoparticles induces genomic instability and DNA damage in multiple tissues10.3109/17435390.2014.902520 ↗
15. Silver or silver nanoparticles: A hazardous threat to the environment and human health?
16. Human skin penetration of silver nanoparticles through intact and damaged skin10.1016/j.tox.2008.09.025 ↗
17. Safety evaluation of silver nanoparticles: inhalation model for chronic exposure10.1093/toxsci/kfp032 ↗
18. Silver nanoparticles: Therapeutical uses, toxicity, and safety issues10.1002/jps.24001 ↗
19. Silver nanoparticles in simulated biological media: a study of aggregation, sedimentation, and dissolution10.1007/s11051-010-0022-3 ↗
20. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells10.1016/j.actbio.2010.08.003 ↗
21. Aggregation and dissolution of silver nanoparticles in natural surface water10.1021/es204531y ↗
22. Agglomeration, isolation and dissolution of commercially manufactured silver nanoparticles in aqueous environments10.1007/s11051-009-9783-y ↗
23. Size-controlled dissolution of silver nanoparticles at neutral and acidic pH conditions: kinetics and size changes10.1021/es5023202 ↗
24. Rapid kinetics of size and pH-dependent dissolution and aggregation of silver nanoparticles in simulated gastric fluid10.1021/acs.jpcc.5b03634 ↗
25. Formation of protein Corona on nanoparticles with digestive enzymes in simulated gastrointestinal fluids10.1021/acs.jafc.8b05702 ↗
26. Protein corona-induced modification of silver nanoparticle aggregation in simulated gastric fluid10.1039/C6EN00278A ↗
27. Interaction of lipid vesicle with silver nanoparticle-serum albumin protein corona
28. Synthesis of highly monodisperse citrate-stabilized silver nanoparticles of up to 200 nm: kinetic control and catalytic properties10.1021/cm500316k ↗
29. Influence of artificial gastric juice composition on bioaccessibility of cobalt- and tungsten-containing powders10.1016/j.ijheh.2009.12.006 ↗
30. Size-controlled dissolution of organic-coated silver nanoparticles10.1021/es201686j ↗
31. Behaviour of silver nanoparticles and silver ions in an in vitro human gastrointestinal digestion model10.3109/17435390.2012.726382 ↗
32. High chemical reactivity of silver nanoparticles toward hydrochloric acid10.1016/j.jcis.2006.07.059 ↗
33. Changes in silver nanoparticles exposed to human synthetic stomach fluid: effects of particle size and surface chemistry10.1016/j.scitotenv.2012.12.036 ↗
34. Taylor dispersion analysis, resonant mass measurement and bioactivity of pepsin-coated gold nanoparticles10.1016/j.talanta.2017.02.010 ↗
35. Spatial mapping and quantification of soft and hard protein coronas at silver nanocubes10.1021/nl500277c ↗
36. Plasmon coupling in silver nanosphere pairs10.1021/jp912096v ↗